Did You Know?

Editor’s Picks

Latest News

Elevar Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for Rivoceranib in Combination with Camrelizumab as a First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of 2mg/kg Body Weight Every-Four-Weeks for Elfabrio® (pegunigalsidase alfa) ▼ in the EU

Groundhog Day Is Uncertain. Access to Inclusive Mental Health Care Shouldn’t Be. Monarc LLC is the FIRST mental health clinic in Maryland designed solely to address the needs of the disabled

ABERDEEN, Md., Jan. 30, 2026 /PRNewswire/ -- On February 2nd, Monarc LLC officially launches its website, monarcmd.org introducing a first-of-its-kind...

eClinicalWorks and Sunoh.ai Assist Healthy Horizons Clinic Save Over Two Hours Daily on Clinical Documentation

Multispecialty practice transforms patient care, improves operational efficiency, and increases patient engagement with AI medical scribeWESTBOROUGH, Mass.--(BUSINESS WIRE)--#AImedicalscribe--eClinicalWorks, the leading...

KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on...

error: Content is protected !!